| Follow Us: Facebook Twitter


3D Biomatrix adds to team as 3D cell matrices gain market traction

Last year was all about the development and launch of 3D Biomatrix's principal product. This year it's all about gaining traction and generating revenues.

"This is the year we get all of the adapters rolling," says Laura Schrader, CEO of 3D Biomatrix. "This is a real turn-key year for us."

The University of Michigan spin-off (it calls the university's Venture Accelerator in Ann Arbor home) develops and makes 3D cell matrices for cell growth in testing. These small scaffoldings provide small dips for the cells to develop. Most of the current products on the market offer flat surfaces, such as slide or Petri dishes.  

3D Biomatrix launched in 2010 and introduced its product late last year. That process allowed the company to hire one employee and bring on two independent contractors. The start-up expects that this year of evangelizing its product and going for global sales will allow it to add one or two more jobs to its team of three employees and two independent contractors.

"It has been an impressive launch so far," Schrader says.

Schrader recently won the Elevator Pitch contest at the ACE event earlier this month. She hopes to build a lot of little wins like that and new clients to build up 3D Biomatrix this year.

Source: Laura Schrader, CEO of 3D Biomatrix
Writer: Jon Zemke
Signup for Email Alerts
Signup for Email Alerts

Related Company

  • 3D Biomatrix
    401 W. Morgan Road
    Ann Arbor, MI 48108 Website

    3D Biomatrix provides 3D cell culture scaffolds, which serve as substrates for a variety of human tissue analogs. Cells grown on 3D Biomatrix products have been shown to retain a much higher complexity of body response than traditional 2D cell